The New Combined PET-MR System NextGen PET-MR With Syngo MR XA80A: Evaluation of Diagnostic Image Quality and Usability (Software and Hardware) in the Clinical Setting.
NCT06666387 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65
Last updated 2026-04-23
Summary
This clinical investigation is used to evaluate the novel PET-MR scanner and it is a clinical investigation under MDR.
The focus is on the evaluation of the diagnostic image quality in a clinical setting, considering the speed of the examination and the new functionalities to minimize the patient's lying times. Based on the assessment, the defined protocols and measurement sequences are further improved as necessary to optimize the clinical value of the sequences and user interface components.
Conditions
- The Evaluation of a New MD - Combined PET-MR System
Interventions
- DIAGNOSTIC_TEST
-
PET-MR examination
PET-MR examination
Sponsors & Collaborators
-
Siemens Healthcare A/S
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-10-31
- Primary Completion
- 2025-07-31
- Completion
- 2025-07-31
Countries
- Denmark
Study Locations
More Related Trials
-
Imaging Acquisition and Analysis Methods for Optimization of MRI Radiation Oncology Simulation and Response Assessment
NCT02422550 ·Status: RECRUITING
-
Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy Device
NCT02331381 ·Status: TERMINATED ·Phase: PHASE1
-
PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis Therapy
NCT00019565 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluation of Attenuation Correction Accuracy in Positron Emission Tomography-Magnetic Resonance Imaging (PET-MRI)
NCT03423407 ·Status: TERMINATED
-
Enhancing SUV Accuracy of PET/MR for Clinical Trial Qualification
NCT03603925 ·Status: COMPLETED
-
Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response
NCT07211360 ·Status: NOT_YET_RECRUITING
-
Optimization of 18F-FDG PET/CT Response Assessment and Prognostic Evaluation Strategies for High-Metabolism Lymphoma
NCT06795113 ·Status: RECRUITING
-
PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
NCT02084147 ·Status: COMPLETED ·Phase: NA
-
Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma
NCT07301827 ·Status: RECRUITING ·Phase: NA
-
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
NCT04417998 ·Status: COMPLETED ·Phase: PHASE4
-
Clinical Application of the Prototype J-PET Device
NCT06211803 ·Status: COMPLETED
-
PET-MR for Prediction and Monitoring of Response to Neoadjuvant Chemotherapy in Breast Cancer
NCT01190566 ·Status: COMPLETED
-
Integrated Positron Emission Tomography Magnetic Resonance (PET/MR) of Breast Cancer
NCT02766530 ·Status: UNKNOWN ·Phase: PHASE4
-
Application of the CD73-Targeted Probe ⁶⁸Ga-DOTA-mPNE PET/CT Imaging in the Diagnosis of Malignant Tumors
NCT07023640 ·Status: RECRUITING ·Phase: NA
-
Lymph Node Assessment Using Simultaneous 18F-FDG-PET and MRI
NCT02180308 ·Status: COMPLETED
-
Spatiotemporal Dynamics and Prognostic Value of the 18F-FDG PET Neuro-Metabolic Network
NCT07203495 ·Status: ACTIVE_NOT_RECRUITING
-
Diagnostic Comparison of PET-magnetic Resonance and PET-CT in Patients With Oncologic Diseases
NCT02316431 ·Status: COMPLETED
-
A Comparison of FDG-PET Versus MRI Based Target Volume Delineation in Glioblastoma and the Role of FDG-PET/CT in the Alteration of MRI Based Target Volumes.
NCT01083719 ·Status: UNKNOWN ·Phase: PHASE2
-
Dosimetry and Preliminary Clinical Application Study of a Novel Probe Targeting CD73
NCT06995976 ·Status: RECRUITING ·Phase: EARLY_PHASE1
-
New Diagnostics in Neutropenia
NCT05174546 ·Status: UNKNOWN
-
FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer
NCT01931709 ·Status: TERMINATED ·Phase: NA
-
PET/MRI Perfusion and CT Perfusion in Solid Tumors
NCT02314962 ·Status: TERMINATED
-
MRI 3D UTE Hyper-Cones & ZTE for PET/MR Lung Attenuation Correction & for Lung Diagnostic Imaging
NCT03562806 ·Status: TERMINATED ·Phase: NA
-
PET/MR in the Staging and Efficacy Evaluation of Newly Diagnosed NK/T-cell Lymphoma
NCT05662540 ·Status: RECRUITING ·Phase: NA
-
Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals
NCT03125629 ·Status: COMPLETED ·Phase: PHASE2